Both mTOR activity and butyrate presumably exert their greatest influence at early stage colonic neoplastic development [4,5,30]; therefore, a possible preventive approach against CRC would be to combine Wnt hyperactivation by butyrate with pharmacological suppression of mTOR signalling. The gene discussed is MTOR; the disease is colorectal carcinoma.